This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (41)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stephen D. Nightingale, MD; Jonathan D. Jockusch; Ingrid Haslund, RN; Stanley X. Cal, MD; Dolores M. Peterson, MD; Scott D. Loss, MD

Arch Intern Med. 1993;153(11):1313-1318.

Abstract
Background
Survival, and the incidence of events that define the acquired immunodeficiency syndrome (AIDS), are known to be inversely related to the CD4 count in patients with human immunodeficiency virus infection. We wished to quantify this relationship more precisely, particularly for patients with CD4 counts of less than 50/mm³.

Methods
Prospective surveillance for survival and for all AIDS-defining events was performed on all 2682 patients with human immunodeficiency virus infection who had at least one CD4 count performed at a large urban public hospital during a 3-year period. Product-limit survival and incidence of AIDS-defining events were calculated as a function of baseline CD4 count.

Results
The 1-year product-limit survival was 17%±6% for patients after a baseline CD4 count of 1 to 4/mm³; 44%±6% after a count of 5 to 9/mm³; 48% ±5% after a count of 10 to 19/mm³; 51%±4% after a count of 20 to 39/mm³; 62%±5% after a count of 40 to 59/mm³; 71%±4% after a count of 60 to 99/mm³; 79%±3% after a count of 100 to 199/mm³; and 92%±2% after a count of 200 to 499/mm³. One-year survival and baseline CD4 count were related by the following formula: percent 1-year survival=10+32(log₁₀ CD4 count) (R²=.97; P<.001). The 1-year incidence of a first AIDS-defining event and baseline CD4 count were related by the following formula: percent developing AIDS in 1 year=104—36(log₁₀ CD4 count) (R²=.89; P<.001). Similar relationships were calculated between the logarithm of the baseline CD4 count and the 1-year incidence of most AIDS-defining events. These relationships were linear over the CD4 range of 1 to 499/mm³ and over follow-up periods of 6 months to 2 years.

Conclusions
The relationship of the CD4 count to survival, and to the incidence of AIDS-defining events, is logarithmic. This relationship helps explain the substantial differences in 1-year survival associated with baseline CD4 counts in the range below 50/mm³.

(Arch Intern Med. 1993;153:1313-1318)

Author Affiliations
From the Division of General Internal Medicine, University of Texas Southwestern Medical School and Parkland Memorial Hospital, Dallas.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women
Goldie et al.
ANN INTERN MED 1999;130:97-107.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients
Scharfstein et al.
Med Decis Making 1997;17:373-381.
ABSTRACT  

Neurocognitive Impairment Is an Independent Risk Factor for Death in HIV Infection
Ellis et al.
Arch Neurol 1997;54:416-424.
ABSTRACT  

Initial Therapy for Acquired Immunodeficiency Syndrome-Associated Cryptococcosis With Fluconazole
Nightingale
Arch Intern Med 1995;155:538-540.
ABSTRACT  

Early Predictors of Outcome for HIV Patients With Neurological Failure
Bedos et al.
JAMA 1995;273:35-40.
ABSTRACT  

CD4+ T-Lymphocyte Measures in the Treatment of Individuals Infected With Human Immunodeficiency Virus Type 1: A Review for Clinical Practitioners
Turner et al.
Arch Intern Med 1994;154:1561-1573.
ABSTRACT  

Rifabutin Prophylaxis against Mycobacterium avium Complex Infection
Goldschmidt et al.
NEJM 1994;330:436-438.
FULL TEXT